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Ethnic differences in maternal oestrogen levels have been suggested as explaining the significantly higher risk of testicular germ cell
tumours (TGCT) of white men than black men in the United States. We therefore examined levels of maternal oestrogens, as well as
testosterone and alphafetoprotein (AFP), in 150 black and 150 white mothers in the Collaborative Perinatal Project. Serum levels of
estradiol (total, free and bioavailable), estriol, testosterone (total, free and bioavailable), sex hormone binding globulin (SHBG), and
AFP were examined during first and third trimesters. We found that the black mothers, rather than the white mothers, had
significantly higher estradiol levels in first trimester (P¼0.05). Black mothers also had significantly higher levels of all testosterone
(Po0.001) and AFP (Po0.001) in both trimesters. In addition, the ratios of sex hormones (estradiol/testosterone) were significantly
lower among black mothers. These findings provide little support to the oestrogen hypothesis, but are consistent with higher levels of
testosterones and/or AFP being associated with reduced risk of TGCT; alternatively, lower oestrogen/androgen ratios may be
associated with reduced risk.
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The incidence rate of testicular germ cell tumours (TGCT) among
white men in the United States is roughly five times higher than
the rate among black men. In addition, the incidence among white
men has been increasing during the past several decades (Zheng
et al, 1996; McGlynn et al, 2003; Ries et al, 2004), while the
incidence among black men has only recently begun to rise
(McGlynn et al, 2003). The reason for this pronounced ethnic
difference in risk is unknown.
Both molecular and epidemiologic studies have provided
evidence that malignant transformation of testicular germ-cells
occurs during early development (Rorth et al, 2000). It has been
suggested that carcinoma in situ of the testis, a precursor of TGCT,
has its origins in fetal life (Rorth et al, 2000) and that subnormal
androgen exposure and/or increased oestrogen exposure are
potentially important risk factors (Skakkebaek et al, 2001).
Moreover, it is hypothesised that a disturbance in the fetal
programming of gonadal development resulting from an intra-
uterine hormonal imbalance may delay differentiation of germ
cells and render them more susceptible to malignant transforma-
tion (Rajpert-De Meyts et al, 1998).
A well-known hypothesis concerning TGCT has postulated that
increased oestrogenic exposure during fetal life is associated with
risk (Henderson et al, 1979; Sharpe and Skakkebaek, 1993). While
some studies have supported this hypothesis (Moller and
Skakkebaek, 1997; Sabroe and Olsen, 1998), two direct examina-
tions of maternal hormone levels have not (Henderson et al, 1988;
Troisi et al, 2003a). The direct examinations may have been
hampered, however, by somewhat limited sample sizes and by
studying samples drawn at only one time in pregnancy.
We have compared maternal serum levels of estradiol (total, free
and bioavailable), estriol, sex hormone binding globulin (SHBG),
testosterone (total, free and bioavailable) and alphafetoprotein
during first and third trimesters in black and white populations
with contrasting risks of TGCT.
METHODS
Study population
In order to examine the hypotheses of interest, a retrospective
study of 150 pairs of black and white mothers was conducted
among the participants of the United States Collaborative Perinatal
Project (CPP). The CPP was a cohort study originally designed to
examine perinatal risk factors for neurologic disorders in offspring
(Niswander and Gordon, 1972). The study enrolled 41796
pregnant women seen at 12 medical centres (Baltimore, Boston,
Buffalo, Memphis, Minneapolis, New Orleans, New York (two
centres), Philadelphia, Portland, Providence, and Richmond) in
the United States between 1959 and 1965. Some women had more
than one pregnancy during the study, resulting in approximately
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y55000 births, of which 13248 were white boys and 13109 were
black boys. The children born during the study were followed up
until age 7 years. The mothers were asked to donate nonfasting
blood samples at approximately 8-week intervals throughout their
pregnancies. Serum samples have been stored in glass vials at
 201C with no recorded thaws.
Based on previous reports of differences in maternal hormone
levels, power calculations determined that it would be necessary to
examine samples from 150 white and 150 black mothers. Mothers
were selected for inclusion based on characteristics of both the
mother and the baby. Inclusion criteria based on characteristics of
the mother were: first pregnancy, length of gestation between 26
and 48 weeks, and availability of blood samples from both first and
third trimesters. Inclusion criteria based on characteristics of the
baby were: male gender, singleton birth, birthweight equal to or
greater than 500g, baby lived for at least 1 year, and had no
diagnoses of undescended testes, late descending testes, retractile
testes or other malformations possibly related to maternal
hormone levels (i.e., CNS and related musculoskeletal, genito-
urinary, inguinal hernia, hydrocele, supernumerary nipples).
A total of 162 black and 652 white mothers satisfied the study
inclusion criteria. The principal limiting criterion was the
availability of first trimester samples as the median entry time
into the study for the whole CPP population was 20 weeks
gestation. In addition, the nulliparity criterion restricted the study
group to approximately one-third of the whole population. Each
of the 162 black mothers was matched to a white mother on the
closest blood draw dates. The matches were then reordered to
select the 150 pairs best matched on draw dates.
Laboratory assays
All hormone levels were assessed at the Reproductive Endocrine
Research Laboratory of the University of Southern California Keck
School of Medicine. Estriol, estradiol, and testosterone were
determined by well-established and validated radioimmunoassay
methods that are carried out routinely in the laboratory (Katagiri
et al, 1974; Goebelsmann et al, 1979). Estriol was first extracted
with hexane:ethyl acetate (10:1) to remove estrone and estradiol.
Estriol in the aqueous fraction was then extracted with hexane:
ethyl acetate (3:2). A separate serum sample was used to extract
testosterone and estradiol, using ethyl acetate:hexane (3:2). This
was followed by isolation of the two steroids using Celite column
partition chromatography using ethylene glycol as the stationary
phase. Testosterone and estradiol were eluted with 15% ethyl
acetate in isooctane and 40% ethyl acetate in isooctane,
respectively. Appropriate tritiated internal standards were added
to each serum sample, prior to organic solvent extraction, to follow
procedural losses. After drying each fraction, the estriol fraction
was reconstituted in ethanol and the other fractions in assay
buffer. An aliquot of each was taken to determine procedural loss,
and duplicate aliquots were taken for the RIA of each hormone.
Each RIA utilises an iodinated radioligand in conjunction with
a specific antiserum (Diagnostic Systems Laboratories (DSL),
Webster, TX, USA). A 7-point standard was included in each assay.
After an overnight incubation (16–18h), antibody-bound steroid
was separated from unbound steroid by precipitation of the first
antibody with a second antibody (DSL), and subsequent centrifu-
gation.
Sex hormone binding globulin was quantified by direct
chemiluminescent immunoassay using the Immulite analyzer
(Diagnostic Products Corporation, Inglewood, CA, USA). The
SHBG concentration and an average albumin concentration of
pregnant women were then utilised in a validated algorithm with
total testosterone and total estradiol, respectively, to calculate free
testosterone; free- and albumin-bound testosterone (bioavailable
testosterone); free estradiol; and free- and albumin-bound
estradiol (bioavailable estradiol) (Sodergard et al, 1982).
Alphafetoprotein was quantified in serum by a solid-phase, two-
site sequential chemiluminescent immunometric assay on the
Immulite Analyzer (Diagnostic Products Corporation, Inglewood,
CA, USA). The calibration range was up to 300IUml
 1, using the
WHO 1st International Standard 72/225. The analytical sensitivity
of the assay was 0.2IUml
 1. Various dilutions of samples (N¼3)
with high AFP levels demonstrated linearity, with observed/
expected values ranging from 97 to 114%. Evaluation of assay
specificity showed nondetectable crossreactivity with a variety of
relevant proteins, for example, albumin, haemoglobin, transferrin,
IgG.
A total of 68 samples from a single blood pool was assayed for
quality control purposes. Each sample was assigned a unique,
random identification number in order to blind subject identities.
Samples were analysed in a total of 17 batches with each batch
containing four quality control samples. The intra-assay coeffi-
cients of variation ranged between 3.7 and 12.6% for all hormones,
while the inter-assay coefficients of variation ranged between 4.8
and 13.3%.
Statistical analysis
Ratios of sex hormones were calculated using serum levels of total,
free, and albumin-bound estradiol divided by serum levels of total,
free, and albumin-bound testosterone, respectively. The ratios and
serum hormone levels were logarithmically transformed to achieve
approximately normal distributions and the transformed values
were used in all statistical analyses. The geometric means of the
hormone levels are presented. T-tests were employed for the mean
comparison of potential confounding variables. Unmatched
analysis of covariance (ANCOVA) was first used to compare mean
log hormone levels and mean log hormone ratios between black
and white mothers by trimester (first and third trimester),
adjusting only for gestational age at blood draw. In subsequent
analyses, adjustment was also made for maternal age, socio-
economic index, body weight (prepregnancy weight for first
trimester and weight at delivery for third trimester) as continuous
variables, and smoking status at registration as a categorical
variable. Maternal age and socioeconomic index were included
because they differed significantly between the white and black
mothers. Although maternal weight and smoking status at
registration did not differ significantly, adjusting for them resulted
in changes of varying magnitude in the mean log hormone levels.
Thus, they were also included in the final models. Pair-matched
ANCOVA was used to test for differences between first and third
trimester for each ethnic group. The statistical models for this
matched analysis included an intercept for each mother, which
adjusts for mother-level covariates. The homogeneity of between-
trimester differences between the racial groups were determined
using matched ANCOVA models by testing for an interaction
between trimester and ethnicity after adjusting for the covariates
that varied by trimester (i.e., gestational age at blood draw and
body weight). Statistical analyses for this study were performed
using the SAS system, version 8.02 (SAS Institute, Inc., Cary, NC,
USA).
RESULTS
A comparison of demographic characteristics of the participants
found that the black mothers were younger and of lower
socioeconomic status than the white mothers (Table 1). No
significant differences in age at menarche, maternal height,
prepregnancy weight, weight at delivery, or smoking were
observed.
Hormone levels were first examined after adjusting solely for
gestational ages at blood draw (Table 2). There were no significant
differences between the black and white mothers’ levels of
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white mothers had significantly lower levels of SHBG, which
resulted in their having significantly higher levels of free and
bioavailable (free plus albumin-bound) estradiol. In addition, all
testosterone levels (total, free, and bioavailable) and AFP levels
were significantly higher among black mothers in both first and
third trimesters. The ratios of testosterones to estradiols were also
significantly different at both times, with black mothers having
lower ratios than white mothers.
All hormone levels were re-examined after adjustment for
maternal age, smoking status, socioeconomic status, and maternal
weight, in addition to gestational ages at blood draw (Table 2). The
adjustment affected both the estradiol and the SHBG findings.
After adjustment, black mothers had significantly higher levels of
total estradiol in first trimester (P¼0.05), but in third trimester,
there was no difference between any of the estradiol levels, or in
SHBG levels. Similar to the unadjusted results, estriol levels did not
vary between the black and white mothers at either time. Also in
agreement with the unadjusted results, black mothers’ levels of all
testosterones and of AFP remained significantly higher than white
mothers’ levels and black mothers’ estradiol/testosterone ratios
remained significantly lower than the ratios among white mothers
at both time points.
Except for free and bioavailable testosterone, all other hormone
levels and hormone ratios increased significantly from the first
trimester to the third trimester in both white and black mothers
(Table 3). The increases, however, were significantly greater among
white mothers than black mothers for free estradiol, bioavailable
estradiol, AFP, and for the hormone ratios. No significant
difference was observed for the change in levels among the other
measured hormones between white and black mothers. With the
exception of AFP, all other hormones between first and third
trimesters were significantly correlated in both black and white
mothers (Table 4).
DISCUSSION
It has long been suggested that exposure to maternal oestrogens is
associated with TGCT (Henderson et al, 1979; Sharpe and
Skakkebaek, 1993). Three potential mechanisms have since been
postulated: (1) suppression of androgen production, (2) suppres-
sion of androgen receptor expression, and (3) suppression of
secretion of insulin-like hormone 3 (Insl3) (Sharpe, 2003). It is
clear that the first two mechanisms are directly associated with
reduced androgen exposure. Insl3 is responsible for the trans-
abdominal phase of testicular descent during first trimester through
virilisation and outgrowth of the embryonic gubernaculum (Nef
and Parada, 1999). Exposure to maternal oestrogens, including
17a- and b-estradiol, as well as diethylstilbestrol, downregulates
Insl3 expression in embryonic Leydig cells (Emmen et al, 2000;
Nef et al, 2000). On the other hand, based on the finding that
oestrogens negatively regulate Leydig cell development via
inhibition of replication of Leydig-cell precursor cells in adult
and prepubertal rats, it is suggested that this regulatory mecha-
nism may also control the number of Leydig cells in fetal life in
humans (Sharpe and Skakkebaek, 1993). As Leydig cells are the
source of testosterone and Insl3, if the above pathway is correct,
the reduced number of Leydig cells resulting from the excess of
oestrogen would decrease the production of testosterone and Insl3.
Thus, elevated oestrogens during early pregnancy would, in theory,
not only reduce the Insl3 expression but might also decrease
testosterone production, and thus, result in an increased risk of
TGCT. It should be noted, however, that the majority of
undescended testes are located in the inguinal canal, rather than
in the abdomen, suggesting a failure in the second, androgen-
dependent, phase of descent rather than in the Insl3-dependent
first phase. A more androgenic milieu during third trimester, then,
may favour descent, in contrast with a less androgenic milieu.
Ethnic differences in maternal oestrogen and androgen levels
have been reported by several epidemiologic studies. Also
examining mothers in the CPP, Henderson et al (1988) studied
first timester serum samples from 20 white and 20 black women
and found no significant differences in levels of estradiol (total and
free), SHBG or human chorionic gonadotropin. Contrary to
expectation, the levels of total estradiol and free estradiol were
higher in the black mothers (mean total estradiol¼189.4pgdl
 1;
mean free estradiol¼1.66pgdl
 1) than the white mothers (mean
total estradiol¼138.4pgdl
 1; mean free estradiol¼1.28pgdl
 1).
The authors also reported that the black mothers had significantly
higher levels of testosterone (114.4ngdl
 1) than did the white
mothers (77.3ngdl
 1). Serum samples drawn from women at term,
also showed no significant variation in levels of estradiol, estriol,
or estrone between 50 white and 34 black mothers (Troisi et al,
2003a). As with the Henderson et al study, however, the authors
reported that the black mothers had significantly higher testo-
sterone levels than did white mothers. A similar lack of support for
the oestrogen hypothesis was recently reported in a study comparing
Chinese pregnant women to US white pregnant women. The
Chinese women had significantly higher serum levels of estradiol
and estriol at weeks 16 and 27 of gestation than did US white
women (Hsieh et al, 2002). Chinese men, however, have a much
lower incidence rate of TGCT than do US white men.
Our results are in agreement with these previously reported
findings. We found significantly higher testosterone levels among
black women in contrast with white women as did other studies:
(Henderson et al, 1988; Troisi et al, 2003a). We also found higher
total estradiol among black women than white women, which is in
Table 1 Selected characteristics of white and black mothers
White mothers (n¼150) Black mothers (n¼150)
Mean Standard deviation Mean Standard deviation t-test P-value
Age at pregnancy (years) 22.26 3.67 19.65 4.31 o0.01
Age at menarche (years) 12.43 1.44 12.58 1.56 0.40
Prepregnancy weight (lbs) 123.08 17.47 124.55 18.57 0.49
Weight at delivery (lbs) 144.70 18.46 148.68 20.21 0.08
Height (inches) 63.90 2.42 63.55 2.64 0.23
Socioeconomic status index 73.23 17.13 41.29 23.82 o0.01
Smoking at registration
No
a 96 (0.64) 107 (0.71)
Yes
a 54 (0.36) 43 (0.29)
Cigarettes per day 16.74 17.86 11.79 18.91 0.19
aPresented as numbers and proportion.
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White mothers (n¼150) Black mothers (n¼150) White vs black
Hormone Mean
a,b (95% CI) Mean
a,c (95% CI) Mean
a,b (95% CI) Mean
a,c (95% CI) P
b P
c
First trimester
d
Alphafetoprotein (IUml
 1) 6.9 (6.1–7.8) 7.0 (6.1–8.1) 10.7 (9.5–12.2) 10.5 (9.1–12.0) o0.01 o0.01
Total estradiol (ngml
 1) 2.3 (2.1–2.6) 2.2 (2.0–2.5) 2.5 (2.3–2.8) 2.6 (2.4–2.9) 0.26 0.05
Free estradiol (pgml
 1) 24.6 (22.7–26.6) 23.5 (21.5–25.7) 24.8 (22.9–26.8) 25.9 (23.7–28.3) 0.89 0.17
Free and albumin-bound 534.7 (494.3–578.5) 511.8 (468.6–559.0) 538.6 (497.9–582.7) 562.7 (515.2–614.6) 0.90 0.18
Estradiol (pgml
 1)
Total estriol (ngml
 1) 0.8 (0.7–0.9) 0.8 (0.7–0.9) 0.9 (0.8–0.9) 0.8 (0.7–0.9) 0.28 0.54
Total testosterone (ngml
 1) 1.0 (0.9–1.0) 1.0 (0.9–1.1) 1.5 (1.4–1.6) 1.4 (1.3–1.6) o0.01 o0.01
Free testosterone (pgml
 1) 6.1 (5.6–6.6) 6.2 (5.7–6.7) 8.5 (7.9–9.2) 8.4 (7.7–9.1) o0.01 o0.01
Free and albumin-bound testosterone (ngdl
 1) 12.8 (11.8–13.8) 13.0 (12.0–14.2) 17.9 (16.6–19.3) 17.5 (16.1–19.1) o0.01 o0.01
Sex hormone binding globulin (nmoll
 1) 233.1 (217.1–250.2) 231.3 (213.7–250.3) 252.8 (235.5–271.3) 254.7 (235.4–275.7) 0.11 0.12
Ratios
Total estradiol/total testosterone 2.4 (2.2–2.6) 2.2 (2.0–2.5) 1.7 (1.6–1.9) 1.8 (1.6–2.0) o0.01 0.01
Free estradiol/free testosterone 4.1 (3.7–4.5) 3.8 (3.4–4.2) 2.9 (2.6–3.2) 3.1 (2.8–3.5) o0.01 0.02
Free and albumin-bound estradiol/free and albumin-bound testosterone 41.9 (38.0–46.3) 39.3 (35.2–43.9) 30.1 (27.2–33.2) 32.1 (28.7–35.8) o0.01 0.02
Third trimester
e
Alphafetoprotein (IUml
 1) 189.5 (175.3–204.9) 180.3 (165.6–196.3) 207.9 (192.3–224.8) 218.5 (200.7–237.8) 0.10 o0.01
Total estradiol (ngml
 1) 19.2 (17.9–20.5) 19.2 (17.8–20.7) 18.5 (17.3–19.7) 18.4 (17.1–19.9) 0.44 0.51
Free estradiol (pgml
 1) 119.5 (111.5–128.1) 117.2 (108.3–126.7) 106.3 (99.1–113.9) 108.4 (100.2–117.3) 0.02 0.21
Free and albumin-bound estradiol (pgml
 1) 2599.1 (2424.7–2786.0) 2547.5 (2355.3–2755.3) 2309.6 (2154.7–2475.7) 2356.5 (2178.7–2548.7) 0.02 0.21
Total estriol (ngml
 1) 11.2 (10.1–11.9) 11.7 (11.0–12.6) 11.3 (10.6–12.0) 10.8 (10.1–11.6) 0.83 0.13
Total testosterone (ngml
 1) 1.2 (1.1–1.3) 1.3 (1.2–1.4) 2.0 (1.8–2.1) 1.9 (1.7–2.0) o0.01 o0.01
Free testosterone (pgml
 1) 1.3 (1.2–1.3) 1.3 (1.2–1.4) 1.7 (1.6–1.7) 1.6 (1.5–1.7) o0.01 o0.01
Free and albumin-bound testosterone (ngdl
 1) 2.0 (2.0–2.1) 2.1 (2.0–2.2) 2.4 (2.3–2.4) 2.4 (2.3–2.5) o0.01 o0.01
Sex hormone binding globulin (nmoll
 1) 503.2 (478.3–529.5) 514.4 (486.3–544.2) 544.7 (517.7–573.1) 532.9 (503.7–563.7) 0.03 0.43
Ratios
Total estradiol/total testosterone 15.6 (14.4–16.9) 14.8 (13.5–16.2) 9.4 (8.7–10.2) 9.9 (9.1–10.9) o0.01 o0.01
Free estradiol/free testosterone 31.2 (28.7–34.0) 29.5 (26.9–32.5) 18.6 (17.1–20.3) 19.6 (17.9–21.6) o0.01 o0.01
Free and albumin-bound estradiol/free and albumin-bound testosterone 322.9 (296.7–351.5) 305.8 (278.3–336.0) 192.5 (176.9–209.6) 203.3 (185.0–223.4) o0.01 o0.01
aValues are geometric means.
bAdjusted for gestational age of blood draw (continuous).
cAdjusted for maternal age at pregnancy (continuous), smoking at registration (ever/never), social economic index (continuous), gestational age
of blood draw (continuous), and maternal weight (continuous).
dAdjusted maternal weight was prepregnancy weight.
eAdjusted maternal weight was weight at delivery.
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yaccord with other results (Henderson et al, 1988; Hsieh et al, 2002).
If anything, these results may suggest that increased estradiol
levels in first trimester are associated with reduced risk of TGCT,
rather than increased risk. The P-value associated with the
estradiol finding, however, just attained statistical significance
and was unadjusted for multiple comparisons. An alternative
explanation is that increased testosterone levels are associated with
reduced risk of TGCT. Perhaps, however, it is not the absolute level
of hormones that is critical, but the ratio of oestrogen to androgen.
In the current study, black mothers had significantly lower ratios
of sex hormones (oestrogens/androgens) than did white mothers
during both the first and third trimesters. A lower ratio of total
estradiol/total testosterone among black mothers has also been
reported by others (Henderson et al, 1988).
Several studies have reported an association between maternal
estriol and birthweight (Mucci et al, 2003). Parallel associations
between increased birthweight and subsequent breast cancer risk
have suggested that increased maternal estriol is a risk factor for
breast cancer (Ahlgren et al, 2003). In contrast with breast cancer,
most studies of birthweight and TGCT have reported that
decreased birthweight, rather than increased birthweight, is a risk
factor (Coupland et al, 2004), suggesting that maternal estriol
levels might be lower in high-risk populations. The current study
found some evidence to support this postulate. While there was no
significant difference in estriol levels by ethnicity, black mothers
did have higher estriol levels in third trimester than did white
mothers as previously reported by Hsieh et al (2002), who found
that second and third trimester estriol levels were significantly
higher in Chinese mothers than in US white mothers.
A number of prior studies have examined ethnic differences in
maternal serum AFP levels in second trimester. With some
exceptions (Macri et al, 1976; Milunsky et al, 1980), the majority
of studies have reported a higher level of weight-adjusted AFP
among black mothers than white mothers (Crandall et al, 1983;
Johnson, 1985; Baumgarten, 1986; Macri et al, 1987; Drugan et al,
1993; Benn et al, 1997; O’Brien et al, 1997). Ethnic differences in
AFP levels during third trimester, however, have not been
thoroughly studied. In the current research, weight-adjusted AFP
Table 3 Changes of hormone levels between first and third trimesters by racial groups and the significance of the changes between racial groups
a
White mothers
(n¼150)
Black mothers
(n¼150) White mothers vs
black mothers
Hormones Mean
b P-value Mean
b P-value P-value
c
Alphafetoprotein 3.3 o0.01 3.0 o0.01 o0.01
Total estradiol 2.1 o0.01 2.0 o0.01 0.11
Free estradiol 1.6 o0.01 1.5 o0.01 0.02
Free and albumin-bound estradiol 1.6 o0.01 1.5 o0.01 0.02
Total estriol 2.7 o0.01 2.6 o0.01 0.30
Total testosterone 0.2 o0.01 0.3 o0.01 0.36
Free testosterone  0.5 o0.01  0.4 o0.01 0.36
Free and albumin-bound testosterone  0.5 o0.01  0.4 o0.01 0.36
Sex hormone binding globulin 0.8 o0.01 0.8 o0.01 0.98
Ratios
Total estradiol/total testosterone 1.9 o0.01 1.7 o0.01 0.01
Free estradiol/free testosterone 2.1 o0.01 1.9 o0.01 0.01
Free and albumin-bound estradiol/free albumin-bound testosterone 2.1 o0.01 1.9 o0.01 0.01
aMatched analyses.
bMeans of the differences of the natural logarithm of hormone levels.
cAdjusted for gestational age at blood draw (continuous) and maternal weight at pre-
pregnancy and delivery (continuous).
Table 4 Correlations of hormone levels between first and third trimesters by racial groups
White mothers (n¼150) Black mothers (n¼150)
Hormones
Pearson’s correlation
coefficient P-value
Pearson’s correlation
coefficient P-value
Alphafetoprotein  0.07 0.40  0.02 0.77
Total estradiol 0.25 o0.01 0.35 o0.01
Free estradiol 0.41 o0.01 0.49 o0.01
Free and albumin-bound estradiol 0.41 o0.01 0.49 o0.01
Total estriol 0.16 0.05 0.43 o0.01
Total testosterone 0.53 o0.01 0.67 o0.01
Free testosterone 0.57 o0.01 0.56 o0.01
Free and albumin-bound testosterone 0.57 o0.01 0.56 o0.01
Sex hormone binding globulin 0.23 o0.01 0.43 o0.01
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and third trimesters. There was not, however, a significant
correlation in either black or white mothers between first and
third trimester levels of AFP. This lack of correlation may indicate
that events during pregnancy influence AFP level more than they
do levels of oestrogens and androgens, as the vast majority of AFP
is produced by the fetus.
The current study has some strengths as well as some
weaknesses. A major strength was the relatively large sample size,
which granted sufficient statistical power to test the study
hypothesis in both first and third trimesters. Another strength is
that mothers of babies with conditions associated with aberrant
hormone levels were excluded from the study. In addition,
matching on the closest gestational age at blood draw for both
first and third trimester decreased the likelihood of confounding
by gestational age. A potential weakness of the study was the fact
that the hormone levels were measured on samples that had been
stored for roughly 40 years. Although long-term storage might
have affected the hormone levels somewhat, it is unlikely that the
bias is great as the levels in the current study are equivalent to
levels reported in other studies examining newly drawn samples
(Lipworth et al, 1999). A final weakness of the study is that it
examined maternal hormone levels rather than fetal hormone
levels and may not have been an accurate approximation of the
in utero hormonal milieu. Comparisons of maternal and umbilical
cord hormone levels found little correlation between the levels
at term (Troisi et al, 2003b). Whether there is any correlation
between maternal and fetal levels is not presently known and is
unlikely to be examined until hormone assays on very small
amounts of blood can be perfected. Given the uncertainty of the
maternal–fetal correlations at the present time, the results of this,
and other studies based on maternal levels, should be accepted
with some caution.
In conclusion, the current study found little evidence to support
the hypothesis that increased maternal oestrogen levels are
associated with increased risk of TGCT. The data are consistent
with several other hypotheses, however. Increased estradiol in first
trimester may be associated with decreased risk of TGCT.
Increased testosterone and/or increased AFP throughout preg-
nancy may be associated with decreased risk of TGCT, although a
relationship with AFP seems somewhat unlikely. Decreased ratios
of oestrogens/androgens throughout pregnancy may be associated
with decreased risk of TGCT. Finally, an increased risk of estriol in
third trimester may be associated with decreased risk of TGCT.
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